Lang, F
Wojcik, B
Bothur, S
Knecht, C
Falkenburg, J H F
Schroeder, T
Serve, H
Ottmann, O G
Rieger, M A
Article History
First Online: 2 November 2016
Competing interests
: FL and OGO had advisory roles for Novartis, Ariad, Bristol-Myers Squibb and Sanofi Aventis. FL received funding of Novartis. OGO was funded by Novartis and Bristol-Myers Squibb. The remaining authors declare no conflict of interest.